Market & News

Naperol Investments will hold a meeting of the Board of Directors of the Company on 25 February 2026.

The board of TIL at its meeting held on 23 February 2026 has approved fund raising of up to Rs 200 crore through issuance of equity shares on rights basis.

Jyoti Structures announced the successful completion and charging of the 400 kV Multi-Circuit Line in Line Out (LILO) of Pirana (Torrent Power)- Pirana (PowerGrid) at POWERGRID substation, Ahmedabad.

This strategically important line is a key component of the 4.5 GW Renewable Energy evacuation system for Khavda Phase-II.

The project involved execution of 240 circuit kilo meters (CKM) of High Temperature Low Sag (HTLS) line, including three crossings of the Sabarmati River and several critical road crossings in the urban vicinity of Ahmedabad. The team worked through significant challenges such as Right of Way (ROW) constraints, limited shutdown availability, and water-logged locations, adopting innovative construction approaches including porta mats, high-capacity dewatering pumps, and heavy-lift cranes.

Patel Engineering has been declared lowest bidder by Himachal Pradesh Power Corporation (HPPCL) for construction of Renukaji Dam Project (PKG 1) valued at Rs. 910.08 crore.

The project entails construction of three diversion tunnels, each with a diameter of 9.5 meters and lengths of 1379 meters, 1468 meters, and 1590 meters respectively.

It also includes the development of three inlet and outlet portals for the diversion tunnels, along with the construction of access roads spanning 6 kilometres.

In addition, the project involves the installation of hydro-mechanical gates for the diversion tunnels and the execution of instrumentation works to ensure operational efficiency and safety.

Mini Diamonds (India) has secured an order worth Rs 12 crore for supply of lab-grown polished diamonds from a Mumbai based client on 23 February 2026.

Tata Communications and RailTel Corporation of India entered into a strategic association to jointly advance next-generation digital infrastructure globally.

Through this association, RailTel's deep national reach will combine with Tata Communications' digital fabric - of global networks, cloud, and omnichannel communication platforms and cybersecurity to address today's growing challenges.

The association aims to modernise network infrastructure, strengthen cyber protection, enhance customer experiences, enable secure and sovereign cloud adoption for sensitive workloads, and leverage advanced AI-enabled platforms that improve visibility, reliability and performance of digital operations.

For RailTel, the association provides an opportunity to enhance its ability to deliver more advanced services across its existing offerings in data centres, managed services, cloud and cybersecurity. For Tata Communications, it is anticipated to facilitate the extension of its digital fabric into critical public and enterprise environments at national scale, supporting some of the country's most important digital services.

Ministries, state governments, PSUs and enterprises that rely on RailTel's network can expect faster connectivity, more resilient systems and stronger safeguards for data. Citizen-facing services such as railway Wi-Fi, public broadband, surveillance systems and digital governance platforms will also benefit from proposed improved performance and reliability.

This collaboration marks an important step in the Digital India journey, bringing together RailTel's unparalleled physical footprint and public sector experience with Tata Communications' expertise in building secure, high-performance digital ecosystems.

Hindustan Zinc has signed a Memorandum of Understanding (MoU) with Tripura Group to operationalize a manufacturing unit within the company's flagship Zinc Park at Khankhala, Bhilwara district of Rajasthan. The agreement marks an important milestone in Hindustan Zinc's plan to build India's first integrated downstream industrial hub dedicated to zinc-based value chains.

Under the agreement, Hindustan Zinc will provide assured raw material linkage to Tripura Group's proposed unit at the Zinc Industrial Park, supported by a committed long-term offtake arrangement. The partnership reflects a shared commitment to building a robust downstream zinc ecosystem, with investment and production plans aligned to drive scale, efficiency, and sustainable industrial growth in the region.

Commenting on the announcement, Arun Misra, Chief Executive Officer, Hindustan Zinc, said “Zinc Park is a strategic initiative that translates our long-term vision for a resilient and competitive metal value chain into concrete action. Our partnership with Tripura Group demonstrates how targeted collaboration can unlock downstream value and accelerate Make in-India manufacturing. The assured supply arrangements, coupled with performance-linked incentives and renewable energy commitments, will provide investors with the confidence to scale. We are determined to build an ecosystem that supports MSME growth, creates local jobs, and drives technological improvements across the zinc value chain.”

Kingfa Science & Technology (India) announced that the newly set-up unit of the Company situated at Plot No-C-583,C-583A & C-583B Bhiwadi, RIICO Industrial Area, Bhiwadi, Khairthal Tijara, Rajasthan- 301019 has commenced commercial production with effect from 22 February 2026.

Morepen Laboratories has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate valued at approximately Rs 825 crore (USD 91 million) from a leading global pharma major.

Supplies under the mandate are expected to commence within the next 4–5 months, with execution scheduled through Q1 of the following financial year, subject to customary operational and regulatory processes.

Lupin has received the approval from European Commission for its biosimilar ranibizumab, RanluspecTM (for vials and pre-filled syringes), following the recent positive opinion from the Committee for Medicinal Products for Human Use.

Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds and inhibits vascular endothelial growth factor A. Its indications encompass the treatment of patients with neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, proliferative diabetic retinopathy, and choroidal neovascularization.

Lupin's biosimilar ranibizumab will be commercialized by Sandoz across the European Union (excluding Germany). In France, the product will be commercialized by two companies, Sandoz and Biogaran.